BridgeMD
New treatment option for Multiple Sclerosis
Official title Motor-cognitive Performance in People With Multiple Sclerosis
ClinicalTrials.gov ID: NCT06312046
What this study is testing
- What it's testing
- Having a neurological disease such as multiple sclerosis (MS) leads to difficulties in balance and gait with or without concurrent performance of cognitive tasks, hindering activity performance and influencing the possibilities for an independent lifestyle. The investigators have adapted a previously developed balance training program to a highly challenging program specifically directed to MS (HiBalance-MS).
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- an MS diagnosis according to McDonald criteria;
- an overall MS-disability score from 2.0 to 5.5 according to the Expanded Disability Status Scale;
- ability to walk 100 m without aid;
- a maximum score of 24 in the Mini-BESTest (i.e., \< 25 points)
- 18 to 65 years of age
You likely can't join if
- cognitive impairment as indicated by a score \<21 in the Montreal Cognitive Assessment;
- presence of other conditions that would substantially influence balance;
- an MS relapse or change of disease-modifying treatment within the past 8 weeks
The study team makes the final eligibility decision.
Where it's taking place
- Stockholm, Stockholm County, Sweden
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Stockholm, Stockholm County, Sweden. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.